Holiday Sale | Save 50%
SubscribeLogin
Holiday Sale | Save 50%
Published

Petros Pharmaceuticals Faces Default Event, Forced Partial Repayment of Obligations

Summary by reporter.am
Petros Pharmaceuticals, Inc. (NASDAQ:PTPI) encountered a default event, necessitating immediate repayment of outstanding obligations. As outlined in a recent 8-K filing with the Securities and Exchange Commission dated December 10, 2024, the company’s subsidiary, Metuchen Pharmaceuticals LLC, defaulted on a payment due on October 1, 2024, which triggered the acceleration of obligations. The default event […]
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

MetuchenMetuchen
Trending Topics
App Store IconPlay Store Icon
CompanyAboutHistoryMissionBlogTestimonialsGroup SubscriptionsSubscribeGiftFree TrialCareersAffiliates
HelpHelp CenterFAQContact UsFor Educators/LibrariesMedia Bias RatingsOwnership and Factuality RatingsReferral CodeNews SourcesTopics
ToolsAppBrowser ExtensionDaily NewsletterBlindspot Report NewsletterBurst Your Bubble NewsletterTimelines
DonatePrivacy PolicyManage CookiesTerms and Conditions
© 2024 Snapwise Inc
News
For You
Search
BlindspotLocal